Top

Published in:

01-03-2015 | LETTER

Author’s response to: Acid-fast bacilli culture positivity and drug resistance in abdominal tuberculosis

Authors: C. Rodrigues, H. Samant, D. Desai, P. Abraham, A. Joshi, S. George

Published in: Indian Journal of Gastroenterology | Issue 2/2015

Excerpt

We read with interest the correspondence regarding “Acid-fast bacilli: culture positivity and drug resistance in abdominal tuberculosis”. It is well known that breakthrough contamination occurs in TB Mycobacteria Growth Indicator Tube (MGIT) cultures up to 8.1 %; this is even higher for all combined solid media at 21 %. At our CAP- and NABL-accredited mycobacteriology lab, stringent quality control/assurance practices are in place for every batch of cultures put up to avoid any cross contamination with appropriate negative controls being performed at least four times a day to prevent any breakthrough contamination. …

Kontos F, Nicolaou S, Kostopoulos C, et al. Multicenter evaluation of the fully automated Bactec MGIT 960 system for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide: comparison with the radiometric Bactec 460TB system. J Microbiol Methods. 2003;55:331–3.CrossRefPubMed

Title: Author’s response to: Acid-fast bacilli culture positivity and drug resistance in abdominal tuberculosis
Authors: C. Rodrigues
H. Samant
D. Desai
P. Abraham
A. Joshi
S. George
Publication date: 01-03-2015
Publisher: Springer India
Published in: Indian Journal of Gastroenterology / Issue 2/2015
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI: https://doi.org/10.1007/s12664-014-0513-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2015

Trends in the epidemiology of hepatitis B virus infection at a tertiary care hospital: A 10-year retrospective analysis

Evaluation of the impact of celiac disease and its dietary manipulation on children and their caregivers

Acid-fast bacilli culture positivity and drug resistance in abdominal tuberculosis

B cell non-Hodgkin’s lymphoma in chronic hepatitis C virus patients: An interesting relationship

Preresection transarterial chemoembolization for hepatocellular carcinoma

The effects of topical application of metronidazole for treatment of chronic anal fissure: A randomized, controlled pilot study

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials